Outcome of Covid-19 Patients Admitted in Emergency Department of Karnali Academy of Health Sciences, Teaching Hospital
DOI:
https://doi.org/10.3126/jcmsn.v19i1.53330Keywords:
Covid-19, Mortality, Cumulative Survival, Kaplan-Meier.Abstract
Introduction
COVID-19, a global health problem, was first identified in the Hubei province, China. While various clinical features of the diseases have been documented, the complete clinical profile is yet to be understood. The purpose of this study is to evaluate the outcome of Covid-19 after admission in the emergency of KAHS during the year 2021January – 2022 January.
Methods
This is a hospital-based, retrospective, observational study done in the emergency department of Karnali Academy of Health Sciences (KAHS), Jumla. The data was taken from the registry, including the record files of patients with Covid-19 admitted in the hospital from 2020 January to 2021 January. The retrieved data was initially entered in an Excel sheet followed by its analysis. We carried out Kaplan Meier survival distribution analysis to determine the survival probability and predictors of Covid-19.
Results
Of the 516 Covid-19 positive patients who were admitted in the hospital, 53.5% were males. For the total patients, the mean duration of hospital stay was 8.02±5.32 days with the proportion of patients who died during treatment being 3.7% (n=19). As described by the Kaplan-Meier curve and the accompanying survival table, the mean survival time of the overall patients was 36.74 days (95% CI=35.6–37.8). Moreover, the cumulative survival rate was seen prominently decreased for older patients and those admitted in the intensive care unit and/or ventilator.
Conclusion
The increased mortality rates seen in the older patients and those admitted in critical care setting clearly calls for the importance of proper and timely intervention.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Gupta Tula krishna, Kushal Bhattarai, Anusmriti Pal, Smriti Mayur Kasaudhan, Nilu Manandhar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This license enables reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.